drugset / Trial / NCT02762799
Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen®
RandomizedCrossoverOpen-labelOther
Summary
BCD-002-1 is 1 phase clinical trial to evaluate pharmacokinetics, pharmacodynamics and safety of single-injection of Leucostim® to healthy volunteers compared to Neupogen®
Timeline
- Start
- 2016-07-18
- Primary completion
- 2016-11-11
- Completion
- 2016-11-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Leucostim | Unknown | — | Subcutaneous |
| Subject | filgrastim | Protein / enzyme biologic | — | Subcutaneous |